About Andrew Song, MD
Dr. Andrew Song joined Inova Schar Cancer Institute in 2020. His clinical interests include central nervous system, thoracic, genitourinary, breast, gynecologic, hematological, and gastrointestinal malignancies. Dr. Song is experienced with multiple radiotherapy techniques and modalities, including stereotactic radiation (SRS, FSRT, SBRT), HDR brachytherapy, and intensity modulated radiation therapy (IMRT) as well as volumetric modulated arc therapy (VMAT) to provide tailored treatment for his patients.
Dr. Song is originally from Fairfax County and attended Thomas Jefferson High School for Science and Technology. He graduated from Princeton University with a bachelor's degree in molecular biology and received his MD from Case Western Reserve University. He then completed his residency in radiation oncology at Thomas Jefferson University.
His current research interest is focused on innovative technology to improve patient experiences. Dr. Song has presented his work at multiple international meetings, including the American Society of Clinical Oncology, and published in numerous reputable journals, including JAMA Oncology, Journal of the American Academy of Dermatology, Radiotherapy and Oncology, and Journal of Neuro-Oncology.
- American Association for Cancer Research
- American College of Radiation Oncology
- American Society for Radiation Oncology
- Society for Neuro-Oncology
- Korean American Society for Radiation Oncology
- Peer Reviewer, Journal of Thoracic Disease
- Peer Reviewer, American Journal of Medical Quality
Medical EducationCase Western Reserve University School of Medicine 2015
Training Specialty: Transitional
7/1/2015 - 06/30/2016
Training Specialty: Radiation Oncology
07/01/2016 - 6/30/2020